Substance / Medication

Anisindione

Overview

Active Ingredient
anisindione
RxNorm CUI
17941

Indications & Related Conditions

Conditions associated via SNOMED clinical relationships

Administration & Protocol

Dosing, route, and treatment protocol

Administration details including route, dosing schedules, preparation instructions, and contraindications are pending physician authorship.

Monitoring & Follow-Up

Biomarkers relevant to this intervention via related conditions

Clinical Trials

37 trials linked to this intervention

37
Total Trials
12
Recruiting
6
With Results

Research Evidence

Published studies and systematic reviews

Sort:
Effect of Oral Anticoagulants in Atrial Fibrillation Patients with Polypharmacy: A Meta-analysis.
Zheng Yuxiang, Li Siyuan, Liu Xiao et al. · Thromb Haemost · 2025
PMID: 37399842Meta-Analysis
Coronary Artery Bypass Grafting versus Percutaneous Coronary Intervention in Patients with Chronic Total Occlusion.
Kirov Hristo, Fischer Johannes, Caldonazo Tulio et al. · Thorac Cardiovasc Surg · 2025
PMID: 38759955Meta-Analysis
Factor XI as a new target for prevention of thromboembolism in cardiovascular disease: a meta-analysis of randomized controlled trials.
Ali Ahmed E, Awad Mohamed K, Ali Karim et al. · J Thromb Thrombolysis · 2025
PMID: 38762711Meta-Analysis
Bioinformatics Analysis Reveals HIST1H2BH as a Novel Diagnostic Biomarker for Atrial Fibrillation-Related Cardiogenic Thromboembolic Stroke.
Jiang Wenbing, Jiang Lelin, Zhao Xiaoli et al. · Mol Biotechnol · 2025
PMID: 38825608Meta-Analysis
Efficacy of oral anticoagulants in chronic kidney disease and hemodialysis patients with atrial fibrillation: a systematic review and meta-analysis.
Latif Fakhar, Meer Komail K, Shaikh Zain et al. · Minerva Cardiol Angiol · 2025
PMID: 39056431Meta-Analysis
Anticoagulation with anisindione in a patient with a warfarin-induced skin eruption.
Spyropoulos Alex C, Hayth Kimberly A, Jenkins Patricia · Pharmacotherapy · 2003
PMID: 12680483Case Report

Research data from MEDLINE/PubMed

Benefits & Expected Outcomes

Benefits, expected outcomes, efficacy data, and NNT (Number Needed to Treat) are pending physician authorship and evidence review.

Risks & Side Effects

Risk profile, common and serious adverse effects, contraindications, and drug interactions are pending physician authorship.

Related Symptoms

Symptoms associated with conditions this intervention addresses

No related symptoms have been mapped yet. Symptom linkages are derived through associated conditions.

Alternatives & Comparisons

Alternative treatments, comparison data, and clinical decision support are pending physician authorship.

Medical Disclaimer

This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult with a qualified healthcare provider regarding any medical condition or treatment plan.

Do not start, stop, or change any treatment without consulting your healthcare provider.

Health Goals

Goals connected through associated conditions

Quick Facts

Type
Substance / Medication
Fully Specified Name
Anisindione (substance)
SNOMED CT
38122009
UMLS CUI
C0051919
RxNorm CUI
17941

Clinical Data

This intervention maps to 16 entities in the Ltrl knowledge graph.

7
Conditions
4
Biomarkers
3
Specialists
0
Symptoms
37
Clinical Trials

Data is sourced from SNOMED CT, UMLS, and the Ltrl clinical knowledge graph. Content sections marked as pending require physician authorship. Consult a healthcare provider before starting any treatment.